How Long Is Mounjaro Good For — and What Should You Expect Over Time?

How long does a Mounjaro pen stay usable before it expires?

Every Mounjaro KwikPen carries a printed expiry date, and the answer to how long it remains good depends almost entirely on how it is stored. Kept in a fridge at 2–8°C, the pen retains full potency until that date. If a pen has been left at room temperature, a limited window applies, but the exact duration varies and the Patient Information Leaflet is the only source you should trust for that figure. Our prescribers always advise patients to check the leaflet the moment the pen arrives.

Speaking of arrival: Mounjaro from nume reaches you via DPD in plain, unbranded packaging. You will get a tracking notification on your phone, so the pen goes straight into the fridge rather than sitting in a warm hallway. It is a small practical detail, but it matters for a temperature-sensitive medicine.

One thing worth understanding: each KwikPen contains four weekly doses, not one. So a single pen represents a full month of treatment at a given dose. Storing it properly for the entire month, not just until the first injection, is part of looking after your treatment.

How long before Mounjaro starts working, and when do results peak?

This is a question our prescribers hear regularly, and the honest answer is that it depends on which outcome you mean. Appetite tends to shift earlier than the scales do. Many people find hunger feels different within the first two or three weeks, particularly after a dose increase, and if you are curious about the early signals to look for, our guide on how long Mounjaro takes to kick in walks through what typically happens in those opening weeks. Visible weight change typically follows, though it builds gradually rather than arriving all at once.

The clearest evidence comes from the SURMOUNT-1 trial, published in the New England Journal of Medicine, which followed thousands of adults with obesity over 72 weeks. At the highest dose (15 mg), participants achieved an average body-weight reduction of around 20–21%. Weight loss continued to accumulate throughout the trial period rather than plateauing early, which is why patience during the titration phase matters. The first few months, when you are on lower starter doses, are not the months to judge the medicine's full effect, and our dedicated page on how long Mounjaro takes to work explains what to realistically expect as you move through each dose stage. You can read more about what to realistically expect during those early weeks on our page on how long Mounjaro takes to produce weight loss.

NICE's appraisal of tirzepatide (TA1026) also references the 72-week horizon when discussing the evidence base. Results below 5% after six months at the highest tolerated dose prompt a prescriber to reassess continuing treatment.

How long do people typically stay on Mounjaro?

The licence does not set a fixed end date for tirzepatide treatment the way, for example, NICE does for Wegovy (which carries a two-year maximum under its NHS recommendation). Mounjaro treatment continues for as long as it remains clinically appropriate, meaning weight loss is progressing or being maintained, and no safety concerns have emerged. How long someone takes Mounjaro is genuinely individual.

What the evidence does suggest is that stopping treatment tends to reverse some of the progress made. Weight management medicines work alongside biology; they are not a one-time course in the way an antibiotic is. That is not a reason to feel locked in, it is simply an honest framing of how the treatment works, and something a good prescriber will discuss with you before you start. How long people stay on Mounjaro in practice varies widely depending on their goals, response and clinical review outcomes.

If you are considering how treatment fits into your longer-term plans, or wondering what happens at each review stage, our FAQs cover the most common questions.

Does Mounjaro's effectiveness change the longer you take it?

The short answer is: not in a way that should concern most people during licensed use. The SURMOUNT-1 data showed that weight reduction continued to build for most of the 72-week trial, suggesting the medicine's mechanism (stimulating both GIP and GLP-1 receptors to reduce appetite and slow gastric emptying) remains active over time. There is no established evidence of tolerance (the effect wearing off) within a licensed course at the doses studied.

That said, individual responses vary. Some people find weight loss slows after the initial months; others continue to see change right through to their maintenance dose. A prescriber who reviews your progress (rather than just reissuing a prescription automatically) is the right person to interpret what your results mean and whether any adjustment is needed. At nume, every repeat order goes through the same clinical review process as the first, so changes in your response are caught and discussed. You can see how our weight-loss treatment consultations work if you are thinking about starting. For broader context on how tirzepatide compares to the journey of other treatment options, our treatment overview is a useful place to start.

One practical consideration on long-term use: the cost of treatment over many months is worth factoring in early. Eli Lilly's 2025 UK price increase changed the landscape for private patients, and understanding realistic ongoing costs helps you plan. Start your free consultation to talk through the full picture with a prescriber.